MicroPort Orthopedics Launches Medial-Pivot Orthopedic Implants in India

India Pharma Outlook Team | Tuesday, 15 April 2025

MicroPort Orthopedics, a global medical device company located in the United States, has introduced in India the Evolution Medial-Pivot Knee, its second-generation knee replacement product.

This latest knee replacement solution mimics the natural knee stability and motion, improving flexion stability, allowing anatomical movement, and reducing wear. Patient outcomes and satisfaction after total knee replacement are improved.

The knee is internationally acclaimed for its clinical performance and has a survivorship of 98.8% at 17 years and 95% patient satisfaction. Being over 25 years in use, the Medial-Pivot line is also part of more than 1 million procedures carried out in over 70 countries.

To support the launch in India, MicroPort's international experts have conducted specialized training sessions for the surgeons across various Indian cities, along with on-site surgical support. Such an initiative will give Indian patients access to world-class technologies that take care of primary concerns like instability while going up or down stairs and unnatural post-operative knee function.

MicroPort, through its worldwide Joint Academy platform, continues to empower healthcare professionals through up-to-date scientific knowledge and surgical techniques that are led by key opinion leaders from around the world.

"Our mission is to provide innovative and relevant medical solutions that improve patients' lives, and we are committed to making a positive impact in India", said Jonathan Chen, Chief International Business Officer.

Dr Mukesh Parmar, Director and General Manager for South Asia said, "Nearly 50 million patients suffer from knee osteoarthritis in India, affecting their day-to-day chores and lifestyle. Our solutions have a long-established credible history of superior results globally and we are excited to introduce our patented inventive products and technologies to alleviate the aftermath of knee osteoarthritis in our patients. Our goal is to partner with Indian healthcare professionals and institutions to deliver the best possible outcomes for the patients".

© 2025 India Pharma Outlook. All Rights Reserved.